Carregant...
Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response
Glioblastoma multiforme (GBM) is the most common and most aggressive type of primary brain cancer. Since median overall survival with multimodal standard therapy is only 15 months, there is a clear need for additional effective and long-lasting treatments. Dendritic cell (DC) vaccination is an exper...
Guardat en:
| Publicat a: | Immunotargets Ther |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918234/ https://ncbi.nlm.nih.gov/pubmed/27471700 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S40121 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|